Henry Schein Inc at Barclays Global Healthcare Conference Transcript
Good afternoon, everybody. Thanks for joining us today. My name is Matt Miksic. I cover medical devices here at Barclays in the U.S.
I'm very pleased to have with us today the team from Henry Schein, Ron South, SVP and CFO; and Graham Stanley, Head of IR. So thanks, guys, for coming, so much.
Questions & Answers
So maybe I thought we might start with -- I want to take a break here and hear for the questions from the audience if there are any, maybe about 5 or 10 minutes in, but I thought we'd start with just a long-term plan. And going through the slides and taking a look at the sort of market growth and the way that you framed it out. You talked about 6% to 8% organic growth on the top line, 8% to 11% EPS growth.
But the -- it struck me that looking at your markets, you have dental growing in like the 2% to 4% range, but then dental -- and specialty is 5% to 8%; technology,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
